These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 2364393

  • 1. Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: evidence for induction of autocrine growth factor activity.
    Schweigerer L, Breit S, Wenzel A, Tsunamoto K, Ludwig R, Schwab M.
    Cancer Res; 1990 Jul 15; 50(14):4411-6. PubMed ID: 2364393
    [Abstract] [Full Text] [Related]

  • 2. [Increased expression of the MYCN oncogene in human neuroblastoma cells and possible, new therapeutic approaches].
    Schweigerer L, Fotsis T.
    Klin Padiatr; 1991 Jul 15; 203(4):319-22. PubMed ID: 1942938
    [Abstract] [Full Text] [Related]

  • 3. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
    Spengler BA, Lazarova DL, Ross RA, Biedler JL.
    Oncol Res; 1997 Jul 15; 9(9):467-76. PubMed ID: 9495452
    [Abstract] [Full Text] [Related]

  • 4. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
    Ferrandis E, Da Silva J, Riou G, Bénard I.
    Cancer Res; 1994 Apr 15; 54(8):2256-61. PubMed ID: 8174136
    [Abstract] [Full Text] [Related]

  • 5. MYCN-related suppression of functional CD44 expression enhances tumorigenic properties of human neuroblastoma cells.
    Gross N, Balmas Bourloud K, Brognara CB.
    Exp Cell Res; 2000 Nov 01; 260(2):396-403. PubMed ID: 11035936
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.
    McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB, Kern FG.
    Cancer Res; 1993 May 01; 53(9):2168-77. PubMed ID: 8481920
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth.
    Grellier P, De Galle B, Babajko S.
    Cancer Res; 1998 Apr 15; 58(8):1670-6. PubMed ID: 9563481
    [Abstract] [Full Text] [Related]

  • 11. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G, Cesi V, Amendola R, Negroni A, Tanno B, Altavista P, Tonini GP, De Bernardi B, Calabretta B.
    Cancer Res; 1999 Jul 15; 59(14):3365-8. PubMed ID: 10416595
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Altered growth and phenotype in clonal mycN transfectants of the SK-N-SH neuroblastoma cell line.
    Gross N, Miescher G, Beck D, Favre S, Beretta C.
    Int J Cancer; 1994 Oct 01; 59(1):141-8. PubMed ID: 7927894
    [Abstract] [Full Text] [Related]

  • 14. The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma.
    Amler LC, Schürmann J, Schwab M.
    Genes Chromosomes Cancer; 1996 Feb 01; 15(2):134-7. PubMed ID: 8834178
    [Abstract] [Full Text] [Related]

  • 15. High activin A-expression in human neuroblastoma: suppression of malignant potential and correlation with favourable clinical outcome.
    Schramm A, von Schuetz V, Christiansen H, Havers W, Papoutsi M, Wilting J, Schweigerer L.
    Oncogene; 2005 Jan 20; 24(4):680-7. PubMed ID: 15580313
    [Abstract] [Full Text] [Related]

  • 16. Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ.
    Kurebayashi J, McLeskey SW, Johnson MD, Lippman ME, Dickson RB, Kern FG.
    Cancer Res; 1993 May 01; 53(9):2178-87. PubMed ID: 8481921
    [Abstract] [Full Text] [Related]

  • 17. N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth.
    Hatzi E, Murphy C, Zoephel A, Rasmussen H, Morbidelli L, Ahorn H, Kunisada K, Tontsch U, Klenk M, Yamauchi-Takihara K, Ziche M, Rofstad EK, Schweigerer L, Fotsis T.
    Oncogene; 2002 May 16; 21(22):3552-61. PubMed ID: 12032857
    [Abstract] [Full Text] [Related]

  • 18. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.
    Shohet JM, Hicks MJ, Plon SE, Burlingame SM, Stuart S, Chen SY, Brenner MK, Nuchtern JG.
    Cancer Res; 2002 Feb 15; 62(4):1123-8. PubMed ID: 11861392
    [Abstract] [Full Text] [Related]

  • 19. The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness.
    Hecht M, Schulte JH, Eggert A, Wilting J, Schweigerer L.
    Carcinogenesis; 2005 Dec 15; 26(12):2105-15. PubMed ID: 16051641
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.